We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biosimilars Forecasted to Capture 4 Percent of Biologics Sales
Biosimilars Forecasted to Capture 4 Percent of Biologics Sales
Biosimilars are expected to account for roughly 4 percent of all biologics sales over the next 10 years, saving the U.S. healthcare system an estimated $44.2 billion, according to new research that forecasts significantly lower savings from the products than another widely cited study.